Design Therapeutics (DSGN) Shares Issued (2021 - 2026)
Design Therapeutics recorded quarterly Shares Issued of $19.9 million in Q1 2026, up 14119.29% quarter-over-quarter from $140000.0 in Q4 2025, and up 86452.17% year-over-year from N/an in Q1 2025.
Design Therapeutics' Shares Issued history runs 6 years deep, the most recent figure standing at $19.9 million for Q1 2026.
- In Q1 2026, Shares Issued rose 86452.17% year-over-year to $19.9 million; the TTM figure through Mar 2026 stood at $20.1 million (up 51397.44% YoY), while the FY2025 annual figure was $200000.0, up 455.56% from the prior year.
- Shares Issued came in at $19.9 million for Q1 2026 at Design Therapeutics, up from $140000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $19.9 million in Q1 2026 to a low of $1000.0 in Q3 2024.
- A 5-year average of $1.6 million and a median of $23000.0 in 2025 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued slumped 99.94% in 2022 and jumped 86452.17% in 2026, its largest moves.
- Design Therapeutics' Shares Issued stood at $16000.0 in 2022, then surged by 2293.75% to $383000.0 in 2023, then tumbled by 97.65% to $9000.0 in 2024, then jumped by 1455.56% to $140000.0 in 2025, then jumped by 14119.29% to $19.9 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $19.9 million, $140000.0, and $37000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Design Therapeutics | 640.15 Mn | 417.32 Mn | - | 19.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.91 Mn |
| Mar 31, 2026 | 19.91 Mn |
| Dec 31, 2025 | 140,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 151,000.00 |
| Sep 30, 2022 | 151,000.00 |
| Mar 31, 2022 | 156,000.00 |
| Mar 31, 2022 | 156,000.00 |
| Dec 31, 2021 | -254.24 Mn |
| Dec 31, 2021 | -254.24 Mn |
| Jun 30, 2021 | -29,000.00 |
| Jun 30, 2021 | -29,000.00 |
| Mar 31, 2021 | 254.30 Mn |
| Mar 31, 2021 | 254.30 Mn |